Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Study provides a new treatment option for patients with relapsed B-cell lymphoma

Study provides a new treatment option for patients with relapsed B-cell lymphoma

What the federal ‘No Surprises Act’ means in California

What the federal ‘No Surprises Act’ means in California

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Prevalence and evolution of PTSD symptoms in cancer patients during COVID-19 pandemic

Prevalence and evolution of PTSD symptoms in cancer patients during COVID-19 pandemic

MD Anderson and Yingli Pharma announce strategic alliance to advance many oncology programs

MD Anderson and Yingli Pharma announce strategic alliance to advance many oncology programs

New trial could transform the way of caring for people with neuroendocrine tumors

New trial could transform the way of caring for people with neuroendocrine tumors

Defective gene in blood cancers could be treated with already available drugs

Defective gene in blood cancers could be treated with already available drugs

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors

New grant program launches to advance therapeutic discovery for follicular lymphoma

New grant program launches to advance therapeutic discovery for follicular lymphoma

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease

Humoral and cellular response to primary and booster COVID-19 vaccination in immunosuppressed patients

Humoral and cellular response to primary and booster COVID-19 vaccination in immunosuppressed patients

New approach with mRNA preparation reprograms T cells to attack heart fibroblasts

New approach with mRNA preparation reprograms T cells to attack heart fibroblasts

Wistar announces initiation of Phase 2 clinical study of VK-2019 in patients with advanced head and neck cancer

Wistar announces initiation of Phase 2 clinical study of VK-2019 in patients with advanced head and neck cancer

Study finds critical metabolic vulnerability of diffuse large B cell lymphomas

Study finds critical metabolic vulnerability of diffuse large B cell lymphomas

Cancer patients who had breakthrough COVID-19 remain at high risk for hospitalization, death

Cancer patients who had breakthrough COVID-19 remain at high risk for hospitalization, death

LJI researchers discover how loss of TET enzymes can lead to B cell lymphoma

LJI researchers discover how loss of TET enzymes can lead to B cell lymphoma

Amino acid valine plays a key role in the growth of T cell acute lymphoblastic leukemia

Amino acid valine plays a key role in the growth of T cell acute lymphoblastic leukemia

A nematode infection can become severe and deadly with the use of corticosteroids

A nematode infection can become severe and deadly with the use of corticosteroids

Study may lead to a paradigm shift in the care for adults who relapse from large B-cell lymphoma

Study may lead to a paradigm shift in the care for adults who relapse from large B-cell lymphoma

Researchers map how the HTLV-1 virus causes a rare leukemia in some people

Researchers map how the HTLV-1 virus causes a rare leukemia in some people